Cancer Treatment
New findings from the United States, People's Republic of China and France in the area of cancer treatment detailed
Published in Vaccine Weekly, May 17th, 2006
Study 1: A PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation induces CTL capable of lysing human tumors.
According to recent research from the United States, "Fusion proteins created by chromosomal translocations in tumors can create neo-antigenic determinants at the breakpoint, which are unique to the tumor cells but shared by the vast majority of tumors of that histologic type. If the fusion protein is responsible for the malignant transformation, its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-17)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Recombinant Bacillus anthracis protective antigen protects against inhalational challenge - Glioblastoma Multiforme
Study finds novel vaccine curbs brain tumor growth, increases survival - Hepatitis B Vaccine
Translocation motif of hepatitis B virus improves protein vaccination - Marburg Virus
Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus - Shigellosis Vaccine
Shigella flexneri 2a and S. sonnei bivalent invasin complex vaccine is developed - Anthrax
Studies from the United States and India advance knowledge in anthrax research - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
